Log in

NYSE:VAR - Varian Medical Systems Stock Price, Forecast & News

$138.51
-0.72 (-0.52 %)
(As of 12/9/2019 01:14 AM ET)
Today's Range
$138.43
Now: $138.51
$139.99
50-Day Range
$114.01
MA: $126.28
$139.20
52-Week Range
$103.92
Now: $138.51
$142.50
Volume636,453 shs
Average Volume619,540 shs
Market Capitalization$12.59 billion
P/E Ratio29.92
Dividend YieldN/A
Beta0.89
Varian Medical Systems, Inc designs, manufactures, sells, and services medical devices and software products for treating cancer and other medical conditions worldwide. It operates through two segments, Oncology Systems and Proton Solutions. The Oncology Systems segment offers hardware and software products for treating cancer with radiotherapy, fixed field intensity-modulated radiation therapy, image-guided radiation therapy, volumetric modulated arc therapy, stereotactic radiosurgery, stereotactic body radiotherapy, and brachytherapy, as well as related quality assurance equipment. Read More…

Industry, Sector and Symbol

Industry Electromedical equipment
Sub-IndustryHealth Care Equipment
SectorMedical
CUSIP92220P10
Phone650-493-4000

Debt

Price-To-Earnings

Sales & Book Value

Annual Sales$3.23 billion
Cash Flow$5.67 per share
Book Value$19.52 per share

Profitability

Net Income$291.90 million

Miscellaneous

Employees10,062
Market Cap$12.59 billion
Next Earnings Date1/22/2020 (Estimated)
OptionableOptionable

Receive VAR News and Ratings via Email

Sign-up to receive the latest news and ratings for VAR and its competitors with MarketBeat's FREE daily newsletter.


Varian Medical Systems (NYSE:VAR) Frequently Asked Questions

What is Varian Medical Systems' stock symbol?

Varian Medical Systems trades on the New York Stock Exchange (NYSE) under the ticker symbol "VAR."

How were Varian Medical Systems' earnings last quarter?

Varian Medical Systems, Inc. (NYSE:VAR) issued its earnings results on Wednesday, October, 23rd. The medical equipment provider reported $1.21 earnings per share (EPS) for the quarter, hitting the consensus estimate of $1.21. The medical equipment provider earned $878.90 million during the quarter, compared to analysts' expectations of $858.47 million. Varian Medical Systems had a net margin of 9.65% and a return on equity of 24.48%. The business's revenue for the quarter was up 9.6% compared to the same quarter last year. During the same period in the previous year, the company earned $1.16 earnings per share. View Varian Medical Systems' Earnings History.

When is Varian Medical Systems' next earnings date?

Varian Medical Systems is scheduled to release their next quarterly earnings announcement on Wednesday, January 22nd 2020. View Earnings Estimates for Varian Medical Systems.

What guidance has Varian Medical Systems issued on next quarter's earnings?

Varian Medical Systems updated its FY 2020 Pre-Market earnings guidance on Monday, November, 25th. The company provided EPS guidance of $5.30-5.45 for the period, compared to the Thomson Reuters consensus estimate of $5.40. The company issued revenue guidance of $$3.515-3.612 billion, compared to the consensus revenue estimate of $$3.57 billion.

What price target have analysts set for VAR?

8 brokerages have issued 1 year target prices for Varian Medical Systems' shares. Their forecasts range from $129.00 to $165.00. On average, they anticipate Varian Medical Systems' stock price to reach $146.13 in the next twelve months. This suggests a possible upside of 5.5% from the stock's current price. View Analyst Price Targets for Varian Medical Systems.

What is the consensus analysts' recommendation for Varian Medical Systems?

8 Wall Street analysts have issued "buy," "hold," and "sell" ratings for Varian Medical Systems in the last year. There are currently 1 hold rating and 7 buy ratings for the stock, resulting in a consensus recommendation of "Buy." View Analyst Ratings for Varian Medical Systems.

What are Wall Street analysts saying about Varian Medical Systems stock?

Here are some recent quotes from research analysts about Varian Medical Systems stock:
  • 1. Barrington Research analysts commented, "We strongly suspect that radiation that is delivered via the Ethos system will receive very high marks from both clinicians and patients alike. Ethos currently has its CE Mark while a 510(k) regulatory clearance in the U.S. is still pending." (9/23/2019)
  • 2. According to Zacks Investment Research, "Varian ended the fiscal third quarter on a solid note, with strength in the core Oncology arm. Growth in EMEA and China also buoys optimism. In fact, management foresees tremendous opportunities in China for its radiation therapy products. Also, Varian’s proton therapy products pipeline is healthy. Management is optimistic about the recently-closed acquisitions of CyberHeart, Cancer Treatment Services International, Endocare and Alicon. A raised revenue guidance paints a bright picture. While expansion in the operating margin is an added positive, contraction in gross margin raises concern. Additionally, the U.S.-China tariffs have been affecting Varian’s top line for a couple of quarters now. Varian also saw softness in its Proton as well as U.S. and APAC businesses in the quarter. A narrowed EPS view adds to the woes." (7/27/2019)
  • 3. BTIG Research analysts commented, "For its fiscal first quarter, Varian again outperformed on two key metrics: revenue and Oncology gross orders. Revenue of $741.0M topped consensus by ~$20M while Oncology gross orders of $716.5M was ~$60M above estimates. We like that Oncology gross order growth of +17% y/y CC was the highest in a decade and that the strength came from all regions. Still, with VAR shares trading near all-time historical highs, investors were likely seeking perfection. VAR may trade up Thursday, but with gross margins and operating margins coming in below consensus models, we think the positive stock reaction may be just a few dollars." (1/24/2019)

Has Varian Medical Systems been receiving favorable news coverage?

Media stories about VAR stock have trended very negative recently, InfoTrie reports. The research group rates the sentiment of media coverage by reviewing more than six thousand news and blog sources. The firm ranks coverage of companies on a scale of negative five to five, with scores nearest to five being the most favorable. Varian Medical Systems earned a news sentiment score of -3.0 on InfoTrie's scale. They also gave news articles about the medical equipment provider a news buzz of 10.0 out of 10, indicating that recent media coverage is extremely likely to have an impact on the company's share price in the immediate future. View News Stories for Varian Medical Systems.

Who are some of Varian Medical Systems' key competitors?

What other stocks do shareholders of Varian Medical Systems own?

Based on aggregate information from My MarketBeat watchlists, some companies that other Varian Medical Systems investors own include NVIDIA (NVDA), Netflix (NFLX), Micron Technology (MU), Starbucks (SBUX), Thermo Fisher Scientific (TMO), Visa (V), Verizon Communications (VZ), Alibaba Group (BABA), CVS Health (CVS) and Align Technology (ALGN).

Who are Varian Medical Systems' key executives?

Varian Medical Systems' management team includes the folowing people:
  • Mr. Dow R. Wilson, Pres, CEO & Director (Age 60)
  • Mr. Gary E. Bischoping Jr., Sr. VP of Fin. & CFO (Age 51)
  • Mr. John W. Kuo, Sr. VP, Gen. Counsel & Corp. Sec. (Age 56)
  • Ms. Kolleen T. Kennedy, Chief Growth Officer & Pres of Proton Solutions (Age 60)
  • Mr. Kevin O'Reilly, Sr. VP of Global Operations

Who are Varian Medical Systems' major shareholders?

Varian Medical Systems' stock is owned by many different of institutional and retail investors. Top institutional investors include State Street Corp (4.63%), Disciplined Growth Investors Inc. MN (0.80%), Boston Trust Walden Corp (0.50%), Russell Investments Group Ltd. (0.48%), Parametric Portfolio Associates LLC (0.43%) and Sumitomo Mitsui Trust Holdings Inc. (0.37%). Company insiders that own Varian Medical Systems stock include Christopher A Toth, David J Illingworth, Dow R Wilson, Gary E Bischoping Jr, John W Kuo, Kolleen T Kennedy, Magnus Momsen, Mark R Laret, R Andrew Eckert, Susan L Bostrom and Timothy E Guertin. View Institutional Ownership Trends for Varian Medical Systems.

Which major investors are selling Varian Medical Systems stock?

VAR stock was sold by a variety of institutional investors in the last quarter, including California Public Employees Retirement System, Man Group plc, First Trust Advisors LP, Alberta Investment Management Corp, Robeco Institutional Asset Management B.V., Sawgrass Asset Management LLC, BB&T Corp and Parametric Portfolio Associates LLC. Company insiders that have sold Varian Medical Systems company stock in the last year include Christopher A Toth, Dow R Wilson, Gary E Bischoping Jr, John W Kuo, Kolleen T Kennedy, Magnus Momsen, R Andrew Eckert and Timothy E Guertin. View Insider Buying and Selling for Varian Medical Systems.

Which major investors are buying Varian Medical Systems stock?

VAR stock was bought by a variety of institutional investors in the last quarter, including Boston Trust Walden Corp, Kornitzer Capital Management Inc. KS, State of New Jersey Common Pension Fund D, DNB Asset Management AS, Mackay Shields LLC, Zurcher Kantonalbank Zurich Cantonalbank, Fairpointe Capital LLC and Squarepoint Ops LLC. View Insider Buying and Selling for Varian Medical Systems.

How do I buy shares of Varian Medical Systems?

Shares of VAR can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include Vanguard Brokerage Services, TD Ameritrade, E*TRADE, Robinhood, Fidelity and Charles Schwab.

What is Varian Medical Systems' stock price today?

One share of VAR stock can currently be purchased for approximately $138.51.

How big of a company is Varian Medical Systems?

Varian Medical Systems has a market capitalization of $12.59 billion and generates $3.23 billion in revenue each year. The medical equipment provider earns $291.90 million in net income (profit) each year or $4.63 on an earnings per share basis. Varian Medical Systems employs 10,062 workers across the globe.View Additional Information About Varian Medical Systems.

What is Varian Medical Systems' official website?

The official website for Varian Medical Systems is http://www.varian.com/.

How can I contact Varian Medical Systems?

Varian Medical Systems' mailing address is 3100 Hansen Way, Palo Alto CA, 94304. The medical equipment provider can be reached via phone at 650-493-4000 or via email at [email protected]


MarketBeat Community Rating for Varian Medical Systems (NYSE VAR)

Community Ranking:  2.7 out of 5 (star star)
Outperform Votes:  495 (Vote Outperform)
Underperform Votes:  434 (Vote Underperform)
Total Votes:  929
MarketBeat's community ratings are surveys of what our community members think about Varian Medical Systems and other stocks. Vote "Outperform" if you believe VAR will outperform the S&P 500 over the long term. Vote "Underperform" if you believe VAR will underperform the S&P 500 over the long term. You may vote once every thirty days.
This page was last updated on 12/9/2019 by MarketBeat.com Staff

Enter your email address below to receive a concise daily summary of analysts' upgrades, downgrades and new coverage with MarketBeat.com's FREE daily email newsletter.

Yahoo Gemini Pixel